President Joe Biden is moving to surrender to China U.S. patent and trade secret protections on America's COVID-19 vaccines.
A TRIPs waiver will not increase the supply of those materials - Pfizer's vaccine requires 280 materials or components from 19 countries - but it will increase the number of companies that enter the vaccine business.
As Senator Ben Sasse, the Nebraska Republican, wrote in a May 17 Wall Street Journal op-ed, "The developing world lacks vaccine manufacturing, storage, and distribution capacities-and none of these problems are solved by an IP giveaway." Sean Lin, a microbiologist and a former lab director of the viral disease branch of the Walter Reed Army Institute of Research, told Gatestone that the proposed TRIPs waiver "Is a nice political gesture."
Second, a TRIPs waiver will eliminate the most important of the barriers to China making sophisticated vaccines: patent protection.
Which will impede the delivery of COVID-19 vaccines, will also help Beijing develop China's biotech business, one of the ten sectors originally listed in its WTO-noncompliant Made in China 2025 initiative.
At the moment, China has failed miserably when it comes to COVID-19 vaccines.
If the Chinese are able to develop a vaccine industry, they will be more likely to create another disease and spread it, as they maliciously spread SARS-CoV-2, the pathogen causing COVID-19, beyond their borders.
https://www.gatestoneinstitute.org/17393/biden-giving-china-vaccine-tech
No comments:
Post a Comment